T1	DISO 14 22	sangrado
#1	AnnotatorNotes T1	C0019080; Hemorrhage; Pathologic Function
T2	PROC 49 86	resección transuretral de la próstata
#2	AnnotatorNotes T2	C0040771; Transurethral Resection of Prostate; Therapeutic or Preventive Procedure
T3	PROC 102 113	tratamiento
#3	AnnotatorNotes T3	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T4	CHEM 163 174	dutasteride
#4	AnnotatorNotes T4	C0754659; dutasteride; Organic Chemical · Pharmacologic Substance
T5	DISO 181 189	sangrado
#5	AnnotatorNotes T5	C0019080; Hemorrhage; Pathologic Function
T6	PROC 216 253	resección transuretral de la próstata
#6	AnnotatorNotes T6	C0040771; Transurethral Resection of Prostate; Therapeutic or Preventive Procedure
T7	CHEM 352 363	finasteride
#7	AnnotatorNotes T7	C0060389; finasteride; Organic Chemical · Pharmacologic Substance · Hormone
T8	CHEM 366 377	dutasteride
#8	AnnotatorNotes T8	C0754659; dutasteride; Organic Chemical · Pharmacologic Substance
T9	ANAT 411 421	prostático
#9	AnnotatorNotes T9	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T10	CHEM 563 574	dutasteride
#10	AnnotatorNotes T10	C0754659; dutasteride; Organic Chemical · Pharmacologic Substance
T11	PROC 665 676	tratamiento
#11	AnnotatorNotes T11	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T12	PROC 853 859	cegado
#12	AnnotatorNotes T12	C0150108; Blinded; Research Activity
T13	PROC 702 724	valores de hemoglobina
#13	AnnotatorNotes T13	C0518015; Hemoglobin measurement; Laboratory Procedure
T14	PROC 767 772	RTU-P
#14	AnnotatorNotes T14	C0040771; Transurethral Resection of Prostate; Therapeutic or Preventive Procedure
T15	DISO 1042 1077	sintomatología obstructiva urinaria
T16	ANAT 1069 1077	urinaria
#15	AnnotatorNotes T16	C1508753; Urinary system; Body System
T17	PROC 1164 1166	Hb
#16	AnnotatorNotes T17	C0518015; Hemoglobin measurement; Laboratory Procedure
T18	PROC 1100 1105	RTU-P
#17	AnnotatorNotes T18	C0040771; Transurethral Resection of Prostate; Therapeutic or Preventive Procedure
T19	PROC 1204 1209	RTU-P
#18	AnnotatorNotes T19	C0040771; Transurethral Resection of Prostate; Therapeutic or Preventive Procedure
T20	CHEM 1393 1404	dutasteride
#19	AnnotatorNotes T20	C0754659; dutasteride; Organic Chemical · Pharmacologic Substance
T21	PROC 1482 1505	estudio no aleatorizado
#20	AnnotatorNotes T21	C2985410; Controlled Clinical Trials, Non-Randomized; Research Activity
T22	ANAT 78 86	próstata
#21	AnnotatorNotes T22	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T23	CHEM 118 129	dutasteride
#22	AnnotatorNotes T23	C0754659; dutasteride; Organic Chemical · Pharmacologic Substance
T24	ANAT 245 253	próstata
#23	AnnotatorNotes T24	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T25	CHEM 713 724	hemoglobina
#24	AnnotatorNotes T25	C0019046; Hemoglobin; Amino Acid, Peptide, or Protein · Biologically Active Substance
T26	ANAT 787 793	tejido
#25	AnnotatorNotes T26	C0040300; Body tissue; Tissue | C1284837; Entire body tissue; Tissue
T27	PROC 794 802	resecado
#26	AnnotatorNotes T27	C0728940; Excision; Therapeutic or Preventive Procedure
T28	PROC 255 260	RTU-P
#27	AnnotatorNotes T28	C0040771; Transurethral Resection of Prostate; Therapeutic or Preventive Procedure
T29	PROC 379 389	creatinina
#28	AnnotatorNotes T29	C0201975; Creatinine measurement; Laboratory Procedure
T30	PROC 403 421	volumen prostático
#29	AnnotatorNotes T30	C1112586; Prostate volume study; Diagnostic Procedure
T31	PROC 613 618	RTU-P
#30	AnnotatorNotes T31	C0040771; Transurethral Resection of Prostate; Therapeutic or Preventive Procedure
T32	Date 23 37	perioperatorio
#31	AnnotatorNotes T32	C1518988; perioperative; Temporal Concept | C2712230; Perioperative Period; Temporal Concept
T33	Duration 92 98	un mes
T34	Date 190 204	perioperatorio
#32	AnnotatorNotes T34	C1518988; perioperative; Temporal Concept | C2712230; Perioperative Period; Temporal Concept
T35	LIVB 299 308	pacientes
#33	AnnotatorNotes T35	C0030705; Patients; Patient or Disabled Group
T36	LIVB 331 340	pacientes
#34	AnnotatorNotes T36	C0030705; Patients; Patient or Disabled Group
T40	Age 434 437	<50
T41	Neg_cue 445 454	excluidos
T42	LIVB 460 469	pacientes
#35	AnnotatorNotes T42	C0030705; Patients; Patient or Disabled Group
T43	LIVB 518 527	pacientes
#36	AnnotatorNotes T43	C0030705; Patients; Patient or Disabled Group
T44	Dose 575 580	0,5mg
T45	Frequency 580 584	/día
T46	Duration 593 600	30 días
T47	LIVB 638 647	pacientes
#37	AnnotatorNotes T47	C0030705; Patients; Patient or Disabled Group
T48	Neg_cue 661 664	sin
T49	LIVB 837 845	cirujano
#38	AnnotatorNotes T49	C0582175; Surgeon; Professional or Occupational Group
A1	Assertion T40 Negated
A2	Assertion T36 Negated
A3	Assertion T11 Negated
A4	Assertion T7 Negated
A5	Assertion T8 Negated
R1	Negation Arg1:T48 Arg2:T11	
T37	CONC 926 947	prueba no paramétrica
#39	AnnotatorNotes T37	C1709255; Non-Parametric Test; Intellectual Product
T38	Neg_cue 1405 1407	no
T39	CONC 1416 1423	impacto
A6	Assertion T39 Negated
R2	Negation Arg1:T38 Arg2:T39	
T50	Quantifier_or_Qualifier 1424 1437	significativo
A7	Assertion T50 Negated
R3	Has_Quantifier_or_Qualifier Arg1:T39 Arg2:T50	
R4	Negation Arg1:T38 Arg2:T50	
T51	Neg_cue 1490 1492	no
T52	Quantifier_or_Qualifier 1493 1505	aleatorizado
A8	Assertion T52 Negated
R5	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T52	
R6	Negation Arg1:T51 Arg2:T52	
T53	Neg_cue 1265 1267	No
T54	CONC 1273 1284	diferencias
A9	Assertion T54 Negated
#40	AnnotatorNotes T54	C1705241; Delta (difference); Quantitative Concept
R7	Negation Arg1:T53 Arg2:T54	
T55	Quantifier_or_Qualifier 677 686	adicional
A10	Assertion T55 Negated
R8	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T55	
#41	AnnotatorNotes T39	C0521102; Interferes with; Functional Concept
#42	AnnotatorNotes T50	C0750502; Significant; Idea or Concept
T56	Observation 1 7	Efecto
#43	AnnotatorNotes T56	C1518681; Outcome of Therapy; Finding (?)
R9	Used_for Arg1:T23 Arg2:T3	
R11	After Arg1:T56 Arg2:T33	
R12	Causes Arg1:T3 Arg2:T56	
R13	Location_of Arg1:T22 Arg2:T2	
R14	Overlap Arg1:T1 Arg2:T32	
R15	Causes Arg1:T2 Arg2:T1	
T57	Observation 152 158	efecto
#44	AnnotatorNotes T57	C1518681; Outcome of Therapy; Finding (?)
R16	Causes Arg1:T4 Arg2:T57	
R17	Overlap Arg1:T5 Arg2:T34	
R18	Location_of Arg1:T24 Arg2:T6	
R19	Location_of Arg1:T24 Arg2:T28	
R20	Causes Arg1:T6 Arg2:T5	
R21	Experiences Arg1:T36 Arg2:T7	
R22	Experiences Arg1:T36 Arg2:T8	
R23	Negation Arg1:T41 Arg2:T7	
R24	Negation Arg1:T41 Arg2:T8	
R25	Negation Arg1:T41 Arg2:T36	
R26	Location_of Arg1:T9 Arg2:T30	
R27	Has_Age Arg1:T36 Arg2:T40	
R28	Negation Arg1:T41 Arg2:T40	
T58	Result_or_Value 390 397	>2mg/ml
A11	Assertion T58 Negated
R29	Has_Result_or_Value Arg1:T29 Arg2:T58	
R30	Negation Arg1:T41 Arg2:T58	
T59	Result_or_Value 422 427	<30cc
A12	Assertion T59 Negated
R31	Has_Result_or_Value Arg1:T30 Arg2:T59	
R32	Negation Arg1:T41 Arg2:T59	
R33	Experiences Arg1:T36 Arg2:T29	
R34	Experiences Arg1:T36 Arg2:T30	
T60	Quantifier_or_Qualifier 528 540	consecutivos
#45	AnnotatorNotes T60	C1707491; Consecutive; Qualitative Concept
R35	Has_Quantifier_or_Qualifier Arg1:T43 Arg2:T60	
R36	Experiences Arg1:T43 Arg2:T10	
R37	Before Arg1:T10 Arg2:T31	
R38	Experiences Arg1:T43 Arg2:T31	
R39	Has_Dose_or_Strength Arg1:T10 Arg2:T44	
R40	Has_Frequency Arg1:T10 Arg2:T45	
R41	Has_Duration_or_Interval Arg1:T10 Arg2:T46	
T61	Quantifier_or_Qualifier 648 660	consecutivos
#46	AnnotatorNotes T61	C1707491; Consecutive; Qualitative Concept
R42	Has_Quantifier_or_Qualifier Arg1:T47 Arg2:T61	
R43	Experiences Arg1:T47 Arg2:T11	
#47	AnnotatorNotes T55	C1524062; Additional; Functional Concept
T62	CONC 688 695	control
#48	AnnotatorNotes T62	C4553389; Study Control; Conceptual Entity
R44	Before Arg1:T13 Arg2:T14	
T63	CONC 735 749	inmediatamente
#49	AnnotatorNotes T63	C0205253; Immediate; Temporal Concept
R45	After Arg1:T63 Arg2:T14	
R46	Overlap Arg1:T13 Arg2:T63	
R47	Location_of Arg1:T26 Arg2:T27	
T64	CONC 778 802	peso del tejido resecado
#50	AnnotatorNotes T64	C0449818; Weight of resected tissue; Quantitative Concept
R48	Location_of Arg1:T26 Arg2:T14	
T65	CONC 902 921	prueba t de student
#51	AnnotatorNotes T65	C0871453; Students T Test; Intellectual Product
T66	CONC 951 963	Mann-Whitney
#52	AnnotatorNotes T66	C1708930; Mann-Whitney Test; Intellectual Product
T67	CONC 970 995	regresión linear múltiple
#53	AnnotatorNotes T67	C0023733; Linear Regression; Quantitative Concept + C0681923; multiple regression; Qualitative Concept
R50	Location_of Arg1:T16 Arg2:T15	
T68	Quantifier_or_Qualifier 1078 1082	baja
#54	AnnotatorNotes T68	C0441994; Lower - spatial qualifier; Spatial Concept
R51	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T68	
R54	After Arg1:T17 Arg2:T19	
R55	Before Arg1:T17 Arg2:T19	
T70	CONC 1348 1373	regresión linear múltiple
#56	AnnotatorNotes T70	C0023733; Linear Regression; Quantitative Concept + C0681923; multiple regression; Qualitative Concept
R56	Before Arg1:T20 Arg2:T39	
R57	Before Arg1:T3 Arg2:T2	
R58	Before Arg1:T4 Arg2:T6	
R59	Before Arg1:T4 Arg2:T28	
T71	Quantifier_or_Qualifier 1285 1316	estadísticamente significativas
A13	Assertion T71 Negated
#57	AnnotatorNotes T71	C0237881; Statistical Significance; Quantitative Concept
R62	Negation Arg1:T53 Arg2:T71	
R63	Has_Quantifier_or_Qualifier Arg1:T54 Arg2:T71	
R52	Has_Duration_or_Interval Arg1:T23 Arg2:T33	
R10	Negation Arg1:T48 Arg2:T55	
#55	AnnotatorNotes T15	C0749941; URINARY OBSTRUCTIVE SYMPTOMS; Sign or Symptom
A14	Experiencer T35 Patient
A15	Experiencer T36 Patient
A16	Experiencer T42 Patient
A17	Experiencer T43 Patient
A18	Experiencer T47 Patient
A19	Experiencer T49 Other
